Google
MCRB — SERES THERAPEUTICS INC (Healthcare >> Biotechnology)
MCRB FAQ
What is MCRB's P/E ratio?
SERES THERAPEUTICS INC (MCRB) currently trades at a P/E ratio of 8.65.
What is MCRB's ROE?
SERES THERAPEUTICS INC reports a Return on Equity (ROE) of -176.98%.
What is MCRB's dividend yield?
SERES THERAPEUTICS INC offers a dividend yield of 0.00%.
What is MCRB's Deepscope Quality Score?
Deepscope rates MCRB's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MCRB?
Deepscope's AI Timing Score for MCRB is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MCRB belong to?
SERES THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 7.17
Price
-0.16
(-2.18%)
Day Change
|
|
|---|
MCRB, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROEが昨年度比で低い
ROAの伸びが低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.15 From 30 days period |
| News Score | 86 |
| Magic Formula Rank by ROA |
801
|
| Magic Formula Rank by ROE |
801
|
| Magic Formula Rank by ROIC |
1108
|
| Price | 7.17 |
| PBV / Sector |
2.68 / 4.48
|
| Earning Per Share | -4.74 |
| PE / Sector |
8.65 / 16.68
GREAT
|
| PEG or PE/Growth / Sector |
-0.16 / 0.53
|
| Average 1M Daily Value |
0.28 M
GREAT
|
| Average 1W Daily Value |
0.31 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
43% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-04 09:24:16 |
| Symbol | MCRB |
| Name | SERES THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 9.68 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 70.98 / 8,483.11 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 101 Cambridgepark Drive, Cambridge, MA, United States, 02140
Phone: 617 945 9626
Website: https://www.serestherapeutics.com
Employees: 66
Sector: Healthcare >> Biotechnology
Description: Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
